Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-03

Clinical Trial Update: A Study to Compare the Efficacy of Alendronate With and Without Calcium or Calcium Alone In the Treatment of Osteoporosis in Postmenopausal Women (0217-088)(COMPLETED) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing alendronate with and without calcium versus calcium alone in postmenopausal osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Calcium (Calcium)
  • alendronate (alendronate)

Snippet

Sponsor: Organon and Co | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED